Fructus polygoni orientalis (FPO) is widely used in clinical practice in China, especially in treatment of liver diseases including viral hepatitis, liver fibrosis, and liver cirrhosis. However, its pharmacokinetic (PK) alterations in liver fibrotic rats have rarely been reported. To study whether taxifolin, one of the main flavonoids in FPO can be absorbed into blood after oral administration of FPO extract and to compare the differences in pharmacokinetic parameters of taxifolin to normal and liver fibrotic rats induced by porcine serum (PS), a UPLC-MS/MS method was developed and validated for determination of taxifolin in rat plasma using puerarin as the internal standard (IS). All validation parameters met the acceptance criteria according to regulatory guidelines. The results indicated that after treatment of rats with PS alone for 12 weeks, the liver fibrotic model group was built successfully. The taxifolin can be absorbed into the blood after oral administration of the FPO extract. The C max of taxifolin was 1940 ± 502.2 ng/mL and 2648 ± 208.5 ng/mL (p < 0.05), the AUC0∼t of taxifolin was 4949.7 ± 764.89 h·ng/mL and 6679.9 ± 734.26 h·ng/mL (p < 0.05), the AUC0∼∞ of taxifolin was 5049.4 ± 760.7 and 7095.2 ± 962.3 h·ng/mL (p < 0.05), and the mean residence time (MRT) of taxifolin was 2.46 ± 0.412 h and 3.17 ± 0.039 h (p < 0.05) in the normal and fibrotic model groups, respectively. These results confirmed that the pharmacokinetic parameters of taxifolin are altered in liver fibrosis, manifested as C max, AUC0∼t , AUC0∼∞, and the mean residence time (MRT). It suggested that it is essential to consider the characteristics of pharmacokinetics after oral administration of FPO in liver disease patients.
Copyright © 2019 Feili Wei et al.
Conflict of interest statement
The authors declare that there are no conflicts of interests regarding the publication of this paper.
Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry.Clin Ther. 2008 Apr;30(4):641-53. doi: 10.1016/j.clinthera.2008.04.005. Clin Ther. 2008. PMID: 18498913 Clinical Trial.
In vivo pharmacokinetic comparisons of ferulic acid and puerarin after oral administration of monomer, medicinal substance aqueous extract and Nao-De-Sheng to rats.Pharmacogn Mag. 2012 Oct;8(32):256-62. doi: 10.4103/0973-1296.103648. Pharmacogn Mag. 2012. PMID: 24082627 Free PMC article.
A UPLC-MS/MS method for in vivo and in vitro pharmacokinetic studies of psoralenoside, isopsoralenoside, psoralen and isopsoralen from Psoralea corylifolia extract.J Ethnopharmacol. 2014;151(1):609-17. doi: 10.1016/j.jep.2013.11.013. Epub 2013 Dec 4. J Ethnopharmacol. 2014. PMID: 24315982
Plasma pharmacokinetics and cerebral nuclei distribution of major constituents of Psoraleae fructus in rats after oral administration.Phytomedicine. 2018 Jan 1;38:166-174. doi: 10.1016/j.phymed.2017.12.002. Epub 2017 Dec 6. Phytomedicine. 2018. PMID: 29425649
Simultaneous determination of caffeic acid derivatives by UPLC-MS/MS in rat plasma and its application in pharmacokinetic study after oral administration of Flos Lonicerae-Fructus Forsythiae herb combination.J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Feb 15;949-950:7-15. doi: 10.1016/j.jchromb.2013.12.035. Epub 2014 Jan 7. J Chromatogr B Analyt Technol Biomed Life Sci. 2014. PMID: 24441018